HPV-related neoplasias in HIV-infected individuals

European Journal of Cancer

Volumn 37, Issue 10, 2001, Pages 1227-1235

  Del Mistro, A ^a   Chieco Bianchi, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anus; Cervix; Human papillomavirus; Immunodeficiency; Penis; Skin; Squamous intra epithelial lesions; Vagina; Vulva

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS DISEASE; CARCINOGENESIS; DISEASE ASSOCIATION; GENITAL TRACT INFECTION; GYNECOLOGY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; WART VIRUS;

EID: 0034968739     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00107-1     Document Type: Article

References (74)

1. Yohei Ito Memorial Lecture: Papillomaviruses in human cancers
2. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
4. Epidemiology of genital human papillomavirus infection
5. Human papillomaviruses and associated malignancies
6. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia
7. The role of human papillomaviruses in anogenital cancers
8. Immunology of papillomavirus infection
9. Human papillomavirus vaccines for cervical cancer
10. Human papillomavirus vaccines
11. Papillomavirus-like particle vaccines for cervical cancer
12. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia
13. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type
14. Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study
15. Natural history of cervicovaginal papillomavirus infection in young women
16. Cervical cancer
17. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin
18. Human papillomavirus infections in non-melanoma skin cancers from renal transplant recipients and non-immunosuppressed patients
19. The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women
20. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
21. Localization of HIV-1 to human papillomavirus associated cervical lesions
22. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription
23. The human immunodeficiency virus type 1 tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure
24. Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum
25. Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression
26. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons
27. Human immunodeficiency virus infection and female lower genital tract malignancy
28. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women
29. Genital human papillomavirus types in immunocompetent and immunodepressed women in North-East Italy: Prevalence and cytomorphological correlations
30. HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers
31. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus
32. Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/μl and below 100 cells/μl
33. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1
34. Incidence of cervical squamous intraepithelial lesions in HIV-infected women
35. Cervical squamous intraepithelial lesions in HIV-infected women: Prevalence, incidence and regression
36. Is HIV infection a cofactor for cervical squamous cell neoplasia?
37. Human papillomavirus infections of the genital region in human immunodeficiency virus seropositive women: Integration of type 16 correlates with rapid progression
38. Management of cervical neoplasia in human immunodeficiency virus-infected women
39. Invasive cervical cancer among women with AIDS in Europe and USA, 1994-1998
40. High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy
41. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome
42. Risk of invasive cervical cancer among women with, or at risk for, HIV infection
43. The spectrum of AIDS-associated cancers in Africa
44. Cancer is a complication of severe immunosuppression
45. Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus
46. Vulvar intraepithelial neoplasia in women infected with human immunodeficiency virus-1
47. Lower genital tract intraepithelial neoplasia in HIV-infected women: Guidelines for evaluation and management
48. An unusual presentation of vulvar carcinoma in a HIV patient
49. Invasive vulvar carcinoma in two women infected with human immunodeficiency virus
50. Verrucous carcinoma of the vulva in a patient infected with the human immunodeficiency virus
51. Vulvar carcinoma in a 12-year-old girl with vertically acquired human immunodeficiency virus infection
52. Human papillomaviruses and multifocal genital neoplasia
53. Rapid progression of primary vaginal squamous cell carcinoma in a young HIV-infected woman
54. Association of human immunodeficiency virus and anal human papillomavirus infection among homosexual men
55. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men
56. Anal squamous intraepithelial lesions: Relation to HIV and human papillomavirus infection
57. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women
58. National linkage of HIV, AIDS and cancer incidence data. Fourth International AIDS Malignancy Conference
59. Treatment of HIV-associated invasive anal cancer with combined chemoradiation
60. Male sexual behavior and human papillomavirus DNA: Key risk factors for cervical cancer in Spain
61. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease
62. Asymptomatic penile HPV infection: A prospective study
63. Genital human papillomavirus infection and associated penile intraepithelial neoplasia in males infected with the human immunodeficiency virus
64. Clinical course and prognostic factors of human papillomavirus infections in men
65. Human papillomavirus and urological tumours: I. Basic science and role in penile cancer
66. Human papillomavirus-associated penile squamous cell carcinoma in HIV-positive patients
67. HPV-16-positive anal and penile carcinomas in a young man - Anogenital "field effect" in the immunosuppressed male?
68. Skin cancer in renal transplant patients
69. Role of human papillomaviruses in cutaneous and oral manifestations of immunosuppression
70. Epidemiology of plantar verrucae in HIV-infected individuals
71. HIV and conjunctival malignancies
72. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda
73. Oral signs and symptoms in 160 HIV-infected patients